Prime Gamechangers Stocks For The Day: First Majestic Silver Corp. (NYSE:AG)

First Majestic Silver Corp. (NYSE:AG) kept active in technical ratio analysis, on current situation shares price plummeted -2.17% to $7.67. The total volume of 8.48 Million shares held in the session, while on average its shares change hands 5260.94 shares. Mostly ROA known as a comparative measure, it is best to compare it against a firm’s previous ROA numbers or the ROA of a same firm.

Analysts Recommendation

Lets us look over what analysts have to say about performance of the AG. Starting with EPS for the final quarter of this year. EPS is usually the indicator of profitability for the company. According to WSJ analysis, the Q4 2016 current estimates trends were for $0.02 as compared to the next year Q1 current trend of $0.03. While on annual basis the current EPS estimates trend for FY 2017 came in for $0.29 as compared to three months ago $0.09.

The stock prices target chart showed high target of 16.50 kept by analysts at WSJ while the average price target was for 11.46 as compared to current price of 7.67. Somehow, the stock managed to gain BUY ratings by 4 analysts in current tenure as 1 analyst having overweight ratings, 3 recommend as HOLD, 1 gave it as a SELL security for current period. Overall, the consensus ratings were for Overweight by the pool of analysts.

Following previous ticker characteristics, First Majestic Silver Corp. (NYSE:AG) also run on active notice, stock price plummeted -2.17% after traded at $7.67 in most recent trading session.

AG has price to earnings ratio of 153.40 and the price to current year EPS stands at -16.70%. Whereas the traders who further want to see about this, may be interested to see Price to next year’s EPS that would be 180.00%.

To find out the technical position of AG, First Majestic Silver Corp. (NYSE:AG) holds price to book ratio of 2.03 that unearth high-growth companies selling at low-growth prices, but it requires appropriate measurement approach. It has forward price to earnings ratio of 27.39. The price to earnings growth ration calculated as 3.28.

Taking notice on volatility measures, price volatility of stock was 4.34% for a week and 5.26% for a month. The price volatility’s Average True Range for 14 days was 0.48. On these bases, analysts would recommend this stock as an “Active Revolving Stocks.” The firm attains analyst recommendation of 2.70 out of 1-5 scale with week’s performance of -2.54%.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *